. 2021 Oct 11;29(6):437–444. doi: 10.1097/MOO.0000000000000768
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
FIGURE 1.
Dysphonia management pathway for COVID-19 patients. COVID-19, coronavirus disease-2019.